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descriptions of HRQoL issues. The majority of the PROMs 
used in the studies represent adaptations of paediatric or 
adult measures. HRQoL issues were organised into the fol-
lowing categories: physical, cognitive, restricted activities, 
relationships with others, fertility, emotions, body image 
and spirituality/outlook on life.
Conclusion The HRQoL issues presented within this 
review are likely to be informative to health care profes-
sionals and AYAs. The extensive list of issues suggests that 
the impact of a cancer diagnosis and treatment during ado-
lescence and young adulthood is widespread and reflects 
the complexities of this developmental phase.
Keywords Adolescents and young adults (AYAs) · 
Health-related quality of life (HRQoL) · Cancer · Patient 
reported outcome measures (PROMs)
Introduction
Background
In recent years, there has been increased emphasis in health 
care on the development and use of measures which give 
patients the opportunity to rate the physical and psycho-
social impact of illness and treatment [1]. These patient 
reported outcome measures (PROMs) are informative for 
both patient and clinician and contribute valuable informa-
tion for clinical trials and medical decision making [2].
For one group of patients, adolescents and young 
adults (AYA) with cancer, health-related quality of life 
(HRQoL) assessment is especially relevant as, compared 
with children and older adults, this group is regarded as 
particularly vulnerable [3, 4]. Adolescence marks the 
transitional stage linking childhood and adulthood in 
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Purpose For adolescents and young adults (AYAs), the 
impact of a cancer diagnosis and subsequent treatment is 
likely to be distinct from other age groups given the unique 
and complex psychosocial challenges of this developmen-
tal phase. In this review of the literature, we report the 
health-related quality of life (HRQoL) issues experienced 
by AYAs diagnosed with cancer and undergoing treatment.
Methods MEDLINE, EMBASE, CINAHL, PsychINFO 
and the Cochrane Library Databases were searched for 
publications reporting HRQoL of AYAs. Issues generated 
from interviews with AYAs or from responses to patient 
reported outcome measures (PROMs) were extracted.
Results 166 papers were reviewed in full and comprised 
72 papers covering 69 primary studies, 49 measurement 
development or evaluation papers and 45 reviews. Of the 69 
studies reviewed, 11 (16%) used interviews to elicit AYAs’ 
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which puberty occurs. The World Health Organization 
[5] defines adolescents as 10–19 year olds although it is 
recognised that this age definition is not fixed and var-
ies according to gender, biological, cultural and socio-
economic factors. There is also fluidity in what defines 
a young adult and while the World Health Organiza-
tion’s definition of young people includes 10–24  year 
olds, the age range used by other organisations, such the 
Adolescent and Young Adult Oncology Progress Review 
Group, extends to 39 year olds [6].
There are several issues that warrant the classifi-
cation of AYAs as different from paediatrics or older 
adults with cancer. Firstly, the epidemiology of cancer 
in AYAs differs from other age groups. While cancer in 
AYAs is relatively rare, its incidence is increasing and 
is higher than that in children [7–11]. In the UK, 2000 
AYAs (aged between 15 and 24 years) are diagnosed 
with cancer each year which is the second cause of 
death in this age group [12]. Cancer types in this group 
are less prevalent in other age groups and there is evi-
dence to suggest that survival outcomes for some can-
cers in this group have not improved in line with figures 
achieved for paediatric or older adult groups [13–15]. 
Ten per cent of tumours seen in AYAs are predominantly 
childhood tumours, while 30% of tumours have a peak 
in adolescence and include Hodgkin lymphoma, Ewing’s 
sarcoma, osteosarcoma, germ-cell tumours and rare soft-
tissue sarcomas. A final 60% are early-onset adult can-
cers [14, 15].
Adolescence and early adulthood is a unique and com-
plex developmental phase characterised not only by sig-
nificant physical and cognitive changes but also critical 
psychosocial challenges, relating to self-identity, peer 
relationships, development of autonomy, and sexuality. 
This also represents an important life stage with regard 
to education and future goal setting. Given the unique 
life circumstances and challenges of this group, it could 
be argued that the experience and impact of cancer on 
AYAs’ HRQoL will be distinct from other age groups.
According to the World Health Organization Quality 
of Life Group, HRQoL can be defined as a multi-dimen-
sional construct shaped by physical health, psychologi-
cal state, level of independence, social relationships, 
personal beliefs and their relationship to important envi-
ronmental features with HRQoL appraisals shaped by 
coping strategies, goals and expectations [16]. Thus, it 
follows that HRQoL measures for this age group should 
be tailored to AYA-specific issues. HRQoL measures 
developed for paediatric practice often incorporate the 
adolescent years as their recommended upper age limit 
for use. In addition, adolescence and early adulthood 
are often included within the lower age limits of adult 
measures.
Objectives
This review focuses on HRQoL issues experienced by 
AYAs during their diagnosis and treatment for cancer and 
refers to descriptive accounts provided during interviews 
with AYAs with cancer and the content of AYA-specific or 
adapted PROMs. This review will also pave the way for a 
discussion on how these HRQoL issues might be distinct 
from those important to children and older adults. To the 
best of our knowledge, this review is the first of its kind in 
terms of systematically reviewing the literature for HRQoL 
issues faced by AYAs with the specific focus on the diag-
nosis and treatment period rather than the post-treatment or 
survivorship phase which presents its own challenges, such 
as living with long lasting effects of treatment, anxiety over 
leaving the hospital system, readjusting to life after treat-
ment and fear of recurrence [17].
Methods
The protocol for this systematic review was informed by 
the Centre for Reviews and Dissemination guidance for 
undertaking reviews in health care [18] and the reporting 
follows the preferred reporting items of systematic reviews 
and meta-analyses (PRISMA) guidelines [19]. The protocol 
is available from the first author.
Search strategies and criteria for considering studies
An initial scoping of the literature using MEDLINE with 
the following search terms and their synonyms “cancer”, 
“adolescent”, “young adult” and “health-related quality 
of life” generated 8635 records. A revised, more focused 
strategy was adopted and verified by two medical librar-
ians. This strategy used exact major headings (MM) as well 
as medical subject headings (MeSH terms) and applied 
the focus/major concept options with Boolean logic rules 
(Table  1). MEDLINE, EMBASE, CINAHL, PsychINFO 
and the Cochrane Library Databases were searched for 
publications up until May 2015 with no defined start date.
The first phase of the selection process involved three 
independent reviewers (S.S., O.H., J.R.) identifying eligible 
papers based on their titles and abstracts. S.S. screened all 
the papers while O.H. and J.R. independently reviewed half 
the records each. Papers selected by either reviewer were 
included in the second phase of the review process. The 
process was monitored by a further reviewer (A-S.D.). Eng-
lish language publications were eligible for inclusion if they 
assessed HRQoL in AYAs with cancer from the perspec-
tive of the AYA rather than proxy, although papers includ-
ing parent assessments alongside AYAs self-reports were 
accepted. Papers describing trials or patient cohort studies 
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were included. Reviews and reports were also considered 
for descriptive and cross-referencing purposes but not for 
data extraction to avoid duplication. Papers describing the 
development of measures to assess HRQOL in AYAs with 
cancer were also eligible for inclusion for descriptive pur-
poses. Given the variability of age definitions of AYAs in 
the literature, we did not set age cut-offs for inclusion; thus, 
a study was considered for inclusion if it reported including 
adolescents and/or young adults. The focus of the review is 
on issues facing AYAs at the time of diagnosis and treat-
ment, thus papers solely describing the experiences of 
survivors were excluded. Prospective cohort studies cover-
ing post-treatment and studies including patients both on 
and off treatment were however considered for inclusion; 
thus, some of the studies included in our review included 
AYAs off treatment. We note that definitions of survivors 
also vary in the literature and we used the working defini-
tion adopted by the European Organisation of Research and 
Treatment for Cancer (EORTC) Survivorship Task Force 
of any person who has been diagnosed with cancer and is 
off treatment with curative-intent (with the exception of 
maintenance treatment) and disease free (has no evidence 
of active cancer) [20]. Individual case reports and abstracts 
from conference proceedings were also excluded. Duplicate 
records were removed.
Evaluation and data extraction
HRQoL issues were extracted from primary sources and 
recorded using a data extraction form. This task was car-
ried out for all eligible papers and shared between the 
reviewers (S.S., O.H., J.R., R.D.). The extraction forms 
were verified by A-S.D. who also addressed additional que-
ries regarding eligibility of papers. A descriptive synthesis 
of the data was used because of the heterogeneity of stud-
ies in terms of research focus and methods of recording 
HRQoL outcomes. The data extraction sheet identifies the 
age range of participants, research objective, methodol-
ogy used, and HRQoL issues assessed or described using 
formal measurement tools or captured using interviews. A 
separate data recording sheet was used for papers focusing 
on AYA measures with the intention to capture the HRQoL 
issues assessed by the measures.
Results
Literature search
The selection process generated 2671 hits (Fig. 1). Screen-
ing of titles and abstracts identified 587 (22%) papers for 
full review with agreement between reviewers for 1911 
(72%) papers. The subsequent data extraction phase identi-
fied 432 papers of the 587 papers as ineligible for review 
with 245 papers describing the experiences of AYAs post-
treatment and 187 rejected on the basis of subject matter 
(not reporting HRQoL issues), patient group (non-AYA 
with cancer), language (non-English) or type of publica-
tion (case study, conference report, proxy assessment). The 
additional 11 papers were identified through cross-refer-
encing; thus, 166 papers were considered for review. There 
were 45 review papers, 49 papers describing the proper-
ties of questionnaires used with AYAs with cancer and 72 
reporting the results of studies (69 in total) using HRQoL 
as an outcome assessment.
Description of studies
Out of the 69 studies reviewed, 3 included only AYAs in 
their sample using the authors’ definition of AYAs [21–24] 
with an upper age of 39 years used as an inclusion criteria 
in the Adolescent and Young Adult Health Outcomes and 
Patient Experience (AYA HOPE) Study [23, 24]. Young 
adults were the focus of 6 studies [25–30] and again these 
were heterogeneous in terms of age range of inclusion with 
the lowest age of 20 used for 3 studies [26, 29, 30] and 47 
years representing the oldest age [28]. Adolescents were 
described as the focus of 14 studies [31–44] with the age 
for inclusion ranging between 10 years [39, 40, 43] and 23 
years [36]. The remaining studies reviewed included ado-
lescents as part of a larger sample which also included chil-
dren and 9 of these [45–53] treated adolescents (12/13 year 
olds) as a separate group.
Leukaemia, lymphoma, cancer of the central nerv-
ous system and sarcoma were amongst the most common 
disease groups. Several studies provided a comparison of 
HRQOL issues according to disease type (solid versus 
Table 1  Revised strategy
a Terms not identified in PsychINFO, EMBASE or CINAHL
b Exact major subheading search
c Medical subheading
Step Search term
1 MMb Health status indicators  (MeSHc, Major Concept)
2 MM Patient outcome assessment (MeSH, Major Concept)a
3 MM Outcome assessment (Health care) (MeSH, Major 
Concept)a
4 MM Quality of life (MeSH, Major Concept)
5 1 or 2 or 3 or 4
6 Young adult (MeSH)
7 Adolescent
8 6 or 7
9 MM Neoplasms+ (MeSH, Major Concept, Exploded)
10 5 and 8 and 9
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haematological cancers) [54] or subtype [acute myeloid 
leukemia (AML) and acute lymphoblastic leukemia (ALL)] 
[55], disease risk (Hodgkin lymphoma ‘high risk’ vs leuke-
mia ‘low risk’) [56] and treatment status [57]. Some stud-
ies captured HRQoL across the disease/treatment trajectory 
looking at change over time [29]. Comparisons have been 
made with healthy individuals either in terms of reference 
to population norms [24, 57] or the inclusion of a separate 
sample of healthy participants [58]. Patients have also been 
compared according to age group (children versus adoles-
cents) [45, 53, 55]. Finally, patients’ self-reports have been 
compared with proxy assessments in order to identify con-
sistency in reporting of HRQoL issues [38].
The studies reviewed asked AYAs to describe or rate 
their HRQoL using interview questions or self-completed 
questionnaire assessments. Of the 69 studies reviewed, 11 
[25, 28, 32, 34, 39, 42, 49, 50, 59–61] used interviews 
to evaluate the experiences of AYAs and capture HRQoL 
issues. Five studies [25, 34, 50, 59, 61] used open-ended, 
semi-structured interviews and 6 were more structured 
with a particular domain of interest including pain [32], 
fatigue [39, 49], body image [28], romantic relation-
ships and fertility [42]. Three studies [32, 39, 60] used 
interviews to complement the completion of measures. 
The remaining 58 studies reviewed relied solely on the 
use of questionnaires which were either generic in their 
focus (PedsQL) [62] or measured a specific HRQoL con-
cern (Reproductive Concerns Instrument) [38]. PROMS 
selected also varied according to their intended age 
group. Some studies asked AYAs with cancer to complete 
measures designed for adult respondents, for example, 
the EORTC core generic cancer quality of life question-
naire (EORTC-QLQ-C30) [63] was used in four of the 
studies reviewed [22, 26, 45, 55]. Indeed, Trevino et  al. 
Fig. 1  Flow chart of the paper 
selection process
Records identified through 
database search n=2671
(1042 duplicates) 
Articles subsequently excluded 
n=432
245 reports of survivors
71 type of publication (case study, 
letter, short report)
55 did not assess HRQoL
outcomes (or were intervention 
studies)
24 no patient-self-report
14 studies did not include AYAs
14 non - English language
7 studies did not include cancer 
patients
2 duplicates
Full text articles eligible for 
review n=587
Measures
n=49
Articles rejected that did not meet 
the inclusion criteria n=2084
Primary data
n=72
(69 studies)
Reviews
n=45
Papers accepted for review 
n=155
Additional papers 
identified through 
cross-referencing 
n=11
Papers reviewed  n=166
1663Qual Life Res (2017) 26:1659–1672 
1 3
[30] noted that as psychological well-being and distress 
scales have not been validated with young adults, they 
had to look for measures validated in other populations 
(i.e. adults). The majority of studies we reviewed used 
measures which had been either specifically developed 
for AYAs, adolescents or young adults, or which had 
been adapted from paediatric or adult measures to cap-
ture the needs and concerns of AYAs.
Description of measures
Adolescent and/or young adult‑specific measures
Our review captured one measure which was specifically 
designed for both adolescents and young adults with can-
cer: The Cancer Needs Questionnaire-Young People (CNQ-
YP) [64] which includes items relevant to young people 
aged 14–25 years. In addition, two other measures, one 
tumour-specific, the Dutch DUX questionnaire for lower 
extremity bone tumour patients (Bt-DUX) [65] and one 
generic, the Perceived Illness Experience (PIES) Scale 
[66], were developed using children as well as AYAs (up 
to 25 and 24 years respectively). We identified two ado-
lescent measures which are generic in terms of their dis-
ease focus: The Adolescent Quality of Life Instrument 
[67] was piloted with 9–20 year olds and the Hopefulness 
Scale for Adolescents (HSA) [68]. One measure reviewed 
was designed for young adults with testicular cancer (aged 
18–29 years): The Cancer Assessment for Young Adults—
Testicular (CAYA-T) [69]. In addition, there was one meas-
ure designed for children and adolescents (8–18 year olds): 
The Quality of Life in Children and Adolescents with Can-
cer Scale (PEDQOL) [70]. The studies reviewed also used 
several generic measures developed for use with age groups 
covering adolescence, for example the Child Health Ques-
tionnaire (CHQ) [71] is relevant for children aged 10–15 
years and the Behavioural Assessment System for Children 
(BASC) [72] is designed to be used with children aged 
4–18 years. The DISAKIDS measure (DCGM-37) [73] is 
used with school aged children including adolescents [74]. 
The Activities Scale for Kids Performance Version (ASKp) 
[75] was designed for children aged 10–15 years and has 
since been used to assess physical function in adolescents 
with bone tumours aged 10–18.9 years [76] and the Pedi-
atrics Outcomes Data Collection Instrument (PODCI) [77] 
provides an assessment of functional status in children and 
adolescents. The Pediatric Functional Assessment of Ano-
rexia and Cachexia Therapy (peds-FAACT) [78] is specific 
to 7–17 years and includes additional peripheral items for 
10–17 year olds. In addition, the PROMIS Pediatric Meas-
ures selected for use by Hinds et al. [79] were suitable for 
completion by 8–17 year olds.
Adapted existing measures
The majority of questionnaires captured in this review rep-
resent adaptations of paediatric or adult measures and thus 
include different age versions. The PedsQL [62] was the 
most common measurement scale of choice amongst the 
studies reviewed and used in 27 of the 69 studies The Ped-
sQL measurement model captures both generic (core meas-
ure) and disease-specific aspects of measurement with the 
core instrument supplemented by disease-specific (e.g. can-
cer), tumour-specific (e.g. brain) or symptom-specific (e.g. 
fatigue) modules. In terms of age versions, the PedsQL 
offers an adolescent form for 13–18 years and was adapted 
by Ewing et al. [80] to create an AYA form appropriate for 
16–24 years. The Pediatric Cancer Quality of Life Inven-
tory (PCQL-32) [81] and the Quality of Life for Children 
with Cancer (QOLCC) [82] also have adolescent versions 
for 13–18  year olds. The Pediatric Advanced Care Qual-
ity of Life Scale (PAC-QoL) [83] has an adolescent ver-
sion for 13–19 year olds. The KINDL measure of quality 
of life in chronically ill children has an oncology-specific 
as well as adolescent version (KINDL Kiddo) for children 
13–16 years [84]. The Child Health and Illness Profile also 
has an adolescent edition (CHIP-AE) for 11–17 year olds 
[85]. There are also several measures developed with adults 
that have been adapted for use with younger respondents. 
The Health-related Hindrance Inventory (HRHI) [86] was 
adapted for use with adolescents and the Reproductive Con-
cerns Instrument [87] was adapted for use with 12–18 year 
old females with cancer [38]. The Memorial Symptom 
Assessment Scale (MSAS 10–18) was also adapted for 
children and adolescents (aged 10–18 years) [88]. The Min-
neapolis–Manchester Quality of Life (MMQL) Question-
naire has an adolescent form (13–20 years) [89] and the 
Behavioural Affective and Somatic Experiences Scale has 
a child-form (BASES-C) [90] covering AYAs (up to 20 
years). Finally, the 16-Dimensional Health-related Measure 
(16D) [91] represents an adaptation of the adult 15D meas-
ure and is suitable for 12–15 years.
HRQoL issues
HRQoL issues extracted from interviews with AYAs or 
measurement concepts of instruments used in the studies 
reviewed are presented in Table 2.
Physical
AYAs talked about their symptoms such as fatigue, loss 
of strength, pain, cognitive difficulties, hair loss, impaired 
appetite and desire to eat [28, 32, 34, 39, 42, 49, 50, 59, 
61]. Symptoms were recognised as a major theme in 
Moody et  al.’s exploratory study [61] and as a HRQoL 
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domain by Hinds et al. [59]. Physical functioning of AYAs 
with cancer including health status, mobility and symp-
toms (disease- and treatment-related) such as pain, fatigue, 
nausea, discomfort, difficulty sleeping, mobility, anorexia 
and cachexia, is assessed by a number of PROMs (Ped-
sQL instruments, CHQ, CHIP-AE, Bt-DUX, Adolescent 
Quality of Life Instrument, CAYA-T, DCGM-37, ASKp, 
PODCI, PROMIS measures, PCQL-32, QOLCC, PAC-
QOL, BASES-C, MMQI, HRHI, KIDDO and 16-D). The 
PedsQL also includes a fatigue-specific module. Five stud-
ies recorded symptom prevalence and impact using symp-
tom distress or checklist measures [27, 36, 92, 93].
Cognitive functioning
Difficulties thinking and concentrating were described by 
adolescents in Chiang et  al.’s study [49] as impacting on 
their school attendance. Cognitive functioning in terms of 
attentiveness, memory and cognitive fatigue also forms 
part of the CAYA-T, PedsQL (within the school function-
ing subscale and the PedsQL Fatigue measure).
Restricted activities
Symptoms such as fatigue, lack of strength and motivation 
as well as time spent undergoing medical treatment com-
promised participants’ ability to engage in everyday activi-
ties, partake in sports, attend school and interact with oth-
ers [25, 34, 39, 49, 50, 59, 60]. When discussing the impact 
of illness and treatment, adolescents often made reference 
to milestones their peers had reached such as selecting 
colleges and learning to drive [60]. Parents’ over-protec-
tiveness was also perceived by adolescents as a barrier to 
engaging in everyday activities [49]. For adolescents in 
Chiang et al.’s study [49], this lack of participation in activ-
ities was expressed as impairing their self-performance 
and compromising the realisation of talents which also 
impacted on future life plans. Participants of Moody et al.’s 
[61] study described feeling trapped and bored by their 
lack of freedom and loss of a normal life. Poor attendance 
at school resulted in adolescents falling behind their peers 
[49, 61]. However, for participants of Momani et al.’s study 
[50], missing school was described as a positive effect of 
being ill.
PROMs also evaluate the impact of physical health sta-
tus and cognitive functioning on the ability to carry out 
daily activities, most notably self-care, work, education 
and hobbies. (CNQ-YP, PIES, Adolescent Quality of Life 
Instrument, CAYA-T, CHQ, PedsQL, 16-D). The PedsQL 
core measure assesses aspects of school functioning with 
the AYA form adapted to read study/work. In addition, the 
CHIP-AE provides an assessment of achievement (aca-
demic and work).
Relationships with others
Restricted social interactions were a recurring theme 
leaving AYAs feeling disconnected and isolated from 
their peers [25, 34, 50, 59, 61]. There were reports of 
friends “keeping their distance” [34] as well as an insight 
into “true friends” [34, 61]. In addition to losing friend-
ships, there were accounts of opportunities to establish 
new friends amongst fellow patients [50]. Participants 
also described greater value placed on relationships with 
others with friendships taking on a new meaning and 
family ties strengthened and these were seen as an impor-
tant source of comfort [25, 34, 50].
Increased dependency on others came at a time 
when adolescents had recently gained independence 
and resulted in feelings of loss of control [25]. AYAs in 
Enskär’s et al.’s study [34] also talked about strained rela-
tionships with family members.
Opportunities for romantic relationships were also 
described as limited and took on a lower priority due to 
symptoms of fatigue and nausea as well as lowered self-
esteem and prolonged hospital stays [42]. In addition, 
anxiety surrounding fertility was also reported [41] and 
led to concerns about prospects for future relationships. 
Stinson et al. [42] also explored the impact of cancer on 
adolescents’ sexual relationships and discovered that, in 
contrast to the assumptions held by parents, AYAs per-
ceived little impact.
Social functioning is covered by most of the measures 
used in the studies reviewed (CNQ-YP, Bt-DUX, CAYA-
T, PCQL-32, QOLCC, PedsQL, PIES, CHQ, DCGM, 
Adolescent Quality of Life Instrument, PROMIS Meas-
ures, PAC-QoL, KINDL/KIDDO, BASES-C, MMQL 
and 16-D). The PEDQOL and KINDL Kiddo distin-
guishes between relationships with family and friends. 
Social exclusion including peer rejection and bullying is 
assessed by the DCGM, PedsQL and PIES. In addition to 
measuring the impact on family relationships and inter-
actions, some measures examine the perceived impact on 
family members, for example, emotional/time pressures 
on parents, limited family activities and family cohesion 
are assessed by the CHQ while parental behaviour repre-
sents a domain of the PIES. Emotional reactions of others 
also formed part of Enskär et al.’s problem list [34] and 
concern over the feelings of family members was voiced 
in Moody et al.’s study [61]. Dyson et al. [21] used The 
Supportive Care Needs Survey (SCNS) [94] to assess 
AYAs’ concerns about worries of those close to them.
Intimate relationships are a domain of the MMQL and 
sexual functioning is assessed as part of the CAYA-T 
and formed part of the supportive needs assessment used 
by Dyson et  al. [21]. Roper et  al. [27] used the Impact 
1667Qual Life Res (2017) 26:1659–1672 
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of Cancer scale [95] to assess intimate relationships in 
young adults.
Fertility
Concerns over fertility are the focus of one of the meas-
ures reviewed (Reproductive Concerns Instrument, used 
by Quinn et al. [38]) and forms part of the Health Utilities 
Index [96] used by Yaris et al. [97]. Trevino et al. [30] dis-
cussed loss of fertility in the context of causing significant 
unique cancer-related grief amongst young adults.
Emotions
Interviews with AYAs provided accounts of their emotional 
reactions to being ill. Mood was identified as a HRQoL 
domain by Hinds [59] and emotional reactions were a 
major theme reported by Moody et  al. [61]. Participants 
described a greater tendency to become upset [50], as well 
as feelings of vulnerability [25], frustration [49], anger 
[61], and fear over mortality [61]. The impact of cancer on 
self-confidence [34] and self-esteem was also reported [34, 
42] although improvements to self-appraisals were also 
described such as becoming a better, more positive and less 
selfish person [34, 50] as well as feelings of greater matu-
rity [34].
Feelings are evaluated alongside relationships in the 
(CNQ-YP). Assessments of emotional or psychologi-
cal functioning amongst AYAs with cancer include mood 
(Adolescent Quality of Life Questionnaire, BASES-C), 
anxiety (BASC, PROMIS, PedsQL), depression (BASC, 
PROMIS), sadness (PedsQL) preoccupation with cancer 
(PIES), concerns for the future (PedsQL, SCNS), fear of the 
unknown (PedsQL), lack of motivation, anger (PROMIS, 
PedsQL), irritability, vulnerability, hopefulness (HSA), 
confidence and self-esteem/self-worth (CHQ, PODCI).
Body image
Emotions relating to appearance issues such as hair loss 
formed part of the problem list discussed by AYAs in 
Enskär et  al.’s study [34] and was the focus of Snöbohm 
et  al.’s study [28]. Adolescents in Stinson et  al.’s study 
described feeling less attractive and desirable to others 
which in turn impacted on their self-esteem and confidence 
in engaging in romantic relationships [42]. Physical appear-
ance or perceived body image is evaluated as part of the 
PIES, PEDQOL, Bt-DUX, MMQL, 16-D and PedsQL 
Cancer module which includes the item “I don’t look like 
myself”.
Spirituality and outlook on life
The impact of illness on spirituality was explored amongst 
children and adolescents of Kamper et al.’s study [60] and 
altered, often positive, perspectives on life were described 
by adolescents [50] and young adults [25]. The Adoles-
cent Quality of Life Instrument evaluates the meaning of 
being ill. Spirituality is covered by the CAYA-T and is the 
focus of the Spiritual Quality of Life Questionnaire used in 
Kamper et  al.’s interviews [60]. Personal growth amongst 
young adults with cancer was evaluated by Monteiro et al. 
[26] by using the Personal growth subscale of the Psycho-
logical Well-Being Scale [98]. The MMQL assessment also 
provides an insight into outlook on life.
Financial difficulties
Zareifar et al. [55] used the EORTC QLQ C30 [63] to pro-
vide an evaluation of financial difficulties. Roper et al. [27] 
also measured the use of supportive care services and dis-
covered that financial concerns were identified as a major 
reason for accessing such services.
Discussion
From our review of studies reporting the HRQoL impact 
of cancer on AYAs and our examination of the content of 
AYA-specific or adapted PROMs, we have generated a 
comprehensive list of HRQoL issues relevant to AYAs with 
cancer. Researchers interested in measuring the impact of 
cancer and its treatment on the HRQoL of AYAs have used 
a wide range of validated instruments. Measures developed 
with and for adults, such as the EORTC QLQ-C30 provide 
opportunities for the measurement of HRQoL concepts, in 
particular symptoms such as pain, fatigue, nausea and vom-
iting that do not begin and end in the AYA years. Adult and 
paediatric measures have also been adapted to the specific 
issues relevant to AYAs and have AYA versions (PedsQL 
[62]) and finally there are measures which have been devel-
oped with and designed specifically for AYAs (CNQ-YP) 
[64]. Choice of measurement tool is driven by the purpose 
of the study with the focus of some studies refined to a 
particular aspect of HRQoL. The types of HRQoL issues 
captured from these studies thus reflect the purpose of the 
study and measure used.
Interviews, as an alternative or addition to the comple-
tion of questionnaires, provide AYAs the opportunity to 
evaluate aspects of HRQoL which might not be covered in 
existing measures. In addition, interviews with AYAs have 
the potential of offering greater insight into the HRQoL 
issues as expressed by AYAs with issues captured often 
incidental to the main purpose of the research, for example, 
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Kamper et al.’s [60] interviews on spiritual wellbeing also 
generated accounts of emotional and social functioning.
There is widespread agreement within the literature that 
adolescence and early adulthood mark a period of great 
turmoil with accelerated physical, cognitive and emotional 
growth and with this comes challenges regarding sense 
of self and autonomy, interpersonal relationships (family, 
romantic and friends) and decision making regarding the 
future [107]. Indeed, it has been argued that adolescents 
and young adults are not a “homogeneous entity” [108] 
thus they might differ from each other in terms of HRQoL 
concerns—for adolescents, independence from parents, 
peer relationships and educational achievement might be 
more pertinent while young adults might be more con-
cerned with career choices, financial independence and 
establishing intimate relationships in view of starting a 
family. The challenges presented during this period of sig-
nificant developmental transition are exacerbated by a diag-
nosis of cancer. Thus, HRQoL measurement during this 
developmental phase needs to be sensitive to these unique 
challenges.
The studies and measures reviewed in the current paper 
highlight the wide spectrum of HRQoL issues facing AYAs 
and include physical, cognitive, emotional, social and spir-
itual functioning which fit with the general, i.e. non-age 
specific definition of HRQoL offered by the World Health 
Organization. Within these HRQoL domains, there are 
issues which are particularly relevant to AYAs which may 
not be so familiar or relevant to children or older patients, 
for example, within the generic core PedsQL, social func-
tioning includes relationships with peers, social exclusion 
and bullying with the AYA version including items relat-
ing to study and work. Additional domains covered in this 
review include inability to engage in activities enjoyed by 
peers, body image, concerns over reproductive capacity 
and intimate relationships. In addition, this review revealed 
that not all consequences of a cancer diagnosis and treat-
ment are viewed by AYAs as negative with descriptions of 
greater maturity, becoming a better person, positive effects 
of missing school, increased family time and improved 
relationships with others reported (e.g. [34, 50]).
Limitations
One of the main limitations of this review is that the 
HRQoL concerns of AYAs presented in this paper are con-
fined to the content of questions asked of patients. With a 
limited number of interview-based studies giving AYAs 
the opportunity to rate aspects of their cancer or treat-
ment not covered by the questionnaires, it is likely that this 
review might have missed important issues. The studies 
reviewed were mostly cross-sectional and included only 
small numbers of patients; thus, caution is required before 
making generalisations about the HRQoL concerns of this 
patient group. In addition, formal comparisons with other 
age groups and between genders fell beyond the scope of 
this review.
This review is also limited in terms of its descriptive 
synthesis of the data. The heterogeneous nature of the stud-
ies reviewed in terms of their focus, outcomes assessed and 
measures used resulted in data being presented in different 
formats; comparisons between studies were difficult and we 
were not in a position to present prevalence figures for indi-
vidual HRQoL issues. While our review captured issues 
from measures used with AYAs in the studies reviewed, it 
is possible that we overlooked some adult measures with 
content relevant to AYAs. In addition, age definitions of 
adolescents and young adults varied across studies and 
the number of studies focusing exclusively on adolescents 
and young adults was limited, which meant we relied on 
findings from studies including AYAs as part of a sam-
ple including children or older adults. Care was taken to 
report only issues relating to AYAs although this was com-
promised in studies not providing a separate treatment of 
the responses of AYAs. Thus, the list of issues might not 
necessarily be specific to AYAs. In addition, it could be 
argued that we should not treat AYAs as one group [108]. 
However, our review was not designed to produce separate 
lists according to age and we did not attempt to draw age 
comparisons. Although we were interested in issues facing 
AYAs at diagnosis and treatment, our review included stud-
ies with AYAs off treatment as part of their sample; thus, 
our list of issues might include those relevant to patients 
post-treatment. However, it was not the intention of this 
review, to make claims regarding issues which are likely to 
remain post-treatment and the experience of AYA cancer 
survivors.
Further avenues for research could include a more 
detailed analysis of the prevalence of the HRQoL issues 
amongst AYAs with cancer using a more conservative age 
definition such as 14–25 years. In addition, comparisons 
with the cancer experiences of other age groups would also 
merit further study in order to help identify and address the 
unique needs of AYAs.
Conclusion
To the best of our knowledge, this review represents the 
first attempt to systematically review studies and the 
PROMS they have used to capture HRQoL issues as 
described by AYAs undergoing treatment for cancer. From 
this review, we have provided a comprehensive list of 
HRQoL issues for this age group which might be of value 
to clinicians in providing insight into the complexities of 
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the cancer experience for AYAs which in turn will help 
support their consultations with AYAs. This review is also 
informative to AYAs themselves and their significant others 
in terms of preparing them for what life might be like as an 
AYA with cancer.
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